PF-AtlasClinical Trials › NCT04891159

Training in Shared Decision-making of Cystic Fibrosis Centers Competences in the Treatment of CF Related Diabetes in Adult Patients

Shared decision making · Not specified

Registry ID
NCT04891159
Phase
Not specified
Status
Unknown
Drug / intervention
Shared decision making
Sponsor
Hospices Civils de Lyon
Start
2021-09
Enrollment
40
Locations
4

About this trial

Diabetes affects half of cystic fibrosis patients aged 30 years and older. It develops asymptomatically for a long time. Also, two options are possible: start insulin treatment now with the additional constraints associated with cystic fibrosis or wait while monitoring the patient's clinical status and initiate insulin treatment when he has developed symptoms and therefore later. In practice, the choice between these two options takes place over two medical consultations without a formalized shared decision-making process between the doctor and the patient. Shared decision-making is a decision-making process in which the healthcare provider and the patient learn about patients care options and then deliberate to reach a common agreement on the decision taken. Shared decision-making seemed particularly relevant to us in cystic fibrosis where there are complex treatment options with variable short-, medium- and long-term side effects and where the disease and its treatments have a high impact on the patient's quality of life.

View NCT04891159 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT04891159 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.